Close-up corporate site, Neuroventi Co., Ltd., improving awareness of small and medium-sized enterprises.

On February 2, 2018, at the close-up corporate site, the contents of the interview with the company (Neuroventi) were released.

In the interview, you can see an interview with CEO Shin Chan-young on the possibility of developing future treatments for brain development disorders, Alzheimer's dementia, stroke, and Parkinson's disease, as well as information on major developments such as autism spectrum disorder treatment, ADHD treatment, and natural product treatment search system. there is.